UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions
{
"resourceType" : "Bundle",
"id" : "Xylocain-20mgml-InjSol-SE-AJ-MPD-BBDL",
"type" : "collection",
"entry" : [
{
"fullUrl" : "https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/MedicinalProductDefinition/Xylocain-20mgml-InjSol-SE-AJ-MPD",
"resource" : {
"resourceType" : "MedicinalProductDefinition",
"id" : "Xylocain-20mgml-InjSol-SE-AJ-MPD",
"meta" : {
"profile" : [
🔗 "http://unicom-project.eu/fhir/StructureDefinition/PPLMedicinalProductDefinition"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"MedicinalProductDefinition_Xylocain-20mgml-InjSol-SE-AJ-MPD\"> </a><p class=\"res-header-id\"><b>Generated Narrative: MedicinalProductDefinition Xylocain-20mgml-InjSol-SE-AJ-MPD</b></p><a name=\"Xylocain-20mgml-InjSol-SE-AJ-MPD\"> </a><a name=\"hcXylocain-20mgml-InjSol-SE-AJ-MPD\"> </a><a name=\"hcXylocain-20mgml-InjSol-SE-AJ-MPD-en-US\"> </a><p><b>identifier</b>: <code>http://ema.europa.eu/fhir/mpId</code>/SE-100001718-00003553, <code>http://ema.europa.eu/fhir/eurdId</code>/10934</p><p><b>domain</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000000004 100000000012}\">Human use</span></p><p><b>status</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/200000005003 200000005004}\">Current</span></p><p><b>combinedPharmaceuticalDoseForm</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/200000000004 100000073863}\">Solution for injection</span></p><p><b>indication</b>: </p><div><p>Intravenös regional anestesi, infiltrationsanestesi, nervblockader, epiduralanestesi. Anestesi av fingrar, tår, öron, näsa och penis eller i andra fall då adrenalin anses kontraindicerat. Vid små operativa ingrepp, då mycket kortvarig anestesi önskas. Xylocain 5 mg/ml och Xylocain 10 mg/ml är avsett för vuxna och barn över 1 år. Xylocain 20 mg/ml är avsett för vuxna.</p>\n</div><p><b>legalStatusOfSupply</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000072051 100000072084}\">Medicinal product subject to medical prescription</span></p><p><b>classification</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000093533 100000097196}\">lidocaine</span></p><blockquote><p><b>name</b></p><p><b>productName</b>: Xylocain 20 mg/ml Injektionsvätska, lösning</p><blockquote><p><b>part</b></p><p><b>part</b>: Xylocain</p><p><b>type</b>: <span title=\"Codes:{http://spor.ema.europa.eu/v1/lists/220000000000 220000000002}\">Invented Name Part</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: 20 mg/ml</p><p><b>type</b>: <span title=\"Codes:{http://spor.ema.europa.eu/v1/lists/220000000000 220000000004}\">Strength part</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: Injektionsvätska, lösning</p><p><b>type</b>: <span title=\"Codes:{http://spor.ema.europa.eu/v1/lists/220000000000 220000000005}\">Pharmaceutical dose form part</span></p></blockquote><h3>Usages</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Country</b></td><td><b>Language</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000000002 100000000535}\">Kingdom of Sweden</span></td><td><span title=\"Codes:{urn:ietf:bcp:47 sv}\">Swedish</span></td></tr></table></blockquote></div>"
},
"identifier" : [
{
"system" : "http://ema.europa.eu/fhir/mpId",
"value" : "SE-100001718-00003553"
},
{
"system" : "http://ema.europa.eu/fhir/eurdId",
"value" : "10934"
}
],
"domain" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000000004",
"code" : "100000000012",
"display" : "Human use"
}
]
},
"status" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/200000005003",
"code" : "200000005004",
"display" : "Current"
}
]
},
"combinedPharmaceuticalDoseForm" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/200000000004",
"code" : "100000073863",
"display" : "Solution for injection"
}
]
},
"indication" : "Intravenös regional anestesi, infiltrationsanestesi, nervblockader, epiduralanestesi. Anestesi av fingrar, tår, öron, näsa och penis eller i andra fall då adrenalin anses kontraindicerat. Vid små operativa ingrepp, då mycket kortvarig anestesi önskas. Xylocain 5 mg/ml och Xylocain 10 mg/ml är avsett för vuxna och barn över 1 år. Xylocain 20 mg/ml är avsett för vuxna.",
"legalStatusOfSupply" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000072051",
"code" : "100000072084",
"display" : "Medicinal product subject to medical prescription"
}
]
},
"classification" : [
{
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000093533",
"code" : "100000097196",
"display" : "lidocaine"
}
]
}
],
"name" : [
{
"productName" : "Xylocain 20 mg/ml Injektionsvätska, lösning",
"part" : [
{
"part" : "Xylocain",
"type" : {
"coding" : [
{
"system" : "http://spor.ema.europa.eu/v1/lists/220000000000",
"code" : "220000000002",
"display" : "Invented Name Part"
}
]
}
},
{
"part" : "20 mg/ml",
"type" : {
"coding" : [
{
"system" : "http://spor.ema.europa.eu/v1/lists/220000000000",
"code" : "220000000004",
"display" : "Strength part"
}
]
}
},
{
"part" : "Injektionsvätska, lösning",
"type" : {
"coding" : [
{
"system" : "http://spor.ema.europa.eu/v1/lists/220000000000",
"code" : "220000000005",
"display" : "Pharmaceutical dose form part"
}
]
}
}
],
"usage" : [
{
"country" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000000002",
"code" : "100000000535",
"display" : "Kingdom of Sweden"
}
]
},
"language" : {
"coding" : [
{
"system" : "urn:ietf:bcp:47",
"code" : "sv",
"display" : "Swedish"
}
]
}
}
]
}
]
}
},
{
"fullUrl" : "https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/RegulatedAuthorization/Xylocain-20mgml-InjSol-SE-AJ-RA",
"resource" : {
"resourceType" : "RegulatedAuthorization",
"id" : "Xylocain-20mgml-InjSol-SE-AJ-RA",
"meta" : {
"profile" : [
🔗 "http://unicom-project.eu/fhir/StructureDefinition/PPLRegulatedAuthorization"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"RegulatedAuthorization_Xylocain-20mgml-InjSol-SE-AJ-RA\"> </a><p class=\"res-header-id\"><b>Generated Narrative: RegulatedAuthorization Xylocain-20mgml-InjSol-SE-AJ-RA</b></p><a name=\"Xylocain-20mgml-InjSol-SE-AJ-RA\"> </a><a name=\"hcXylocain-20mgml-InjSol-SE-AJ-RA\"> </a><a name=\"hcXylocain-20mgml-InjSol-SE-AJ-RA-en-US\"> </a><p><b>identifier</b>: <code>http://ema.europa.eu/fhir/marketingAuthorizationNumber</code>/3553</p><p><b>subject</b>: <a href=\"MedicinalProductDefinition-Xylocain-20mgml-InjSol-SE-AJ-MPD.html\">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100001718-00003553,http://ema.europa.eu/fhir/eurdId#10934; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Solution for injection; indication = Intravenös regional anestesi, infiltrationsanestesi, nervblockader, epiduralanestesi. Anestesi av fingrar, tår, öron, näsa och penis eller i andra fall då adrenalin anses kontraindicerat. Vid små operativa ingrepp, då mycket kortvarig anestesi önskas. Xylocain 5 mg/ml och Xylocain 10 mg/ml är avsett för vuxna och barn över 1 år. Xylocain 20 mg/ml är avsett för vuxna.; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = lidocaine</a></p><p><b>type</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/220000000060 220000000061}\">Marketing Authorisation</span></p><p><b>region</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000000002 100000000535}\">Kingdom of Sweden</span></p><p><b>status</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000072049 100000072099}\">Valid</span></p><p><b>statusDate</b>: 1949-07-20</p><p><b>holder</b>: <a href=\"Organization-LOC-100001575.html\">Organization Aspen Pharma Trading Limited</a></p><h3>Cases</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Type</b></td><td><b>Date[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://ema.europa.eu/fhir/authorisationDateType dateOfFirstAuthorisation}\">First Authorisation</span></td><td>1949-07-20</td></tr></table></div>"
},
"identifier" : [
{
"system" : "http://ema.europa.eu/fhir/marketingAuthorizationNumber",
"value" : "3553"
}
],
"subject" : [
{
🔗 "reference" : "MedicinalProductDefinition/Xylocain-20mgml-InjSol-SE-AJ-MPD"
}
],
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/220000000060",
"code" : "220000000061",
"display" : "Marketing Authorisation"
}
]
},
"region" : [
{
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000000002",
"code" : "100000000535",
"display" : "Kingdom of Sweden"
}
]
}
],
"status" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000072049",
"code" : "100000072099",
"display" : "Valid"
}
]
},
"statusDate" : "1949-07-20",
"holder" : {
🔗 "reference" : "Organization/LOC-100001575"
},
"case" : {
"type" : {
"coding" : [
{
"system" : "https://ema.europa.eu/fhir/authorisationDateType",
"code" : "dateOfFirstAuthorisation",
"display" : "First Authorisation"
}
]
},
"dateDateTime" : "1949-07-20"
}
}
},
{
"fullUrl" : "https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/PackagedProductDefinition/Xylocain-20mgml-InjSol-SE-AJ-PPD",
"resource" : {
"resourceType" : "PackagedProductDefinition",
"id" : "Xylocain-20mgml-InjSol-SE-AJ-PPD",
"meta" : {
"profile" : [
🔗 "http://unicom-project.eu/fhir/StructureDefinition/PPLPackagedProductDefinition"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"PackagedProductDefinition_Xylocain-20mgml-InjSol-SE-AJ-PPD\"> </a><p class=\"res-header-id\"><b>Generated Narrative: PackagedProductDefinition Xylocain-20mgml-InjSol-SE-AJ-PPD</b></p><a name=\"Xylocain-20mgml-InjSol-SE-AJ-PPD\"> </a><a name=\"hcXylocain-20mgml-InjSol-SE-AJ-PPD\"> </a><a name=\"hcXylocain-20mgml-InjSol-SE-AJ-PPD-en-US\"> </a><p><b>identifier</b>: <code>http://ema.europa.eu/example/pcid</code>/?ngen-9?</p><p><b>packageFor</b>: <a href=\"MedicinalProductDefinition-Xylocain-20mgml-InjSol-SE-AJ-MPD.html\">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100001718-00003553,http://ema.europa.eu/fhir/eurdId#10934; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Solution for injection; indication = Intravenös regional anestesi, infiltrationsanestesi, nervblockader, epiduralanestesi. Anestesi av fingrar, tår, öron, näsa och penis eller i andra fall då adrenalin anses kontraindicerat. Vid små operativa ingrepp, då mycket kortvarig anestesi önskas. Xylocain 5 mg/ml och Xylocain 10 mg/ml är avsett för vuxna och barn över 1 år. Xylocain 20 mg/ml är avsett för vuxna.; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = lidocaine</a></p><p><b>containedItemQuantity</b>: 5 Vial<span style=\"background: LightGoldenRodYellow\"> (Details: 200000000014 code200000002158 = '200000002158')</span></p><p><b>description</b>: </p><div><p>Injektionsflaska, 5 x 20 ml</p>\n</div><h3>MarketingStatuses</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Country</b></td><td><b>Status</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000000002 100000000535}\">Kingdom of Sweden</span></td><td><span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000072052 100000072083}\">Marketed</span></td></tr></table><blockquote><p><b>packaging</b></p><p><b>type</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000073346 100000073498}\">Box</span></p><p><b>quantity</b>: 1</p><p><b>material</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/200000003199 200000003529}\">Cardboard</span></p><blockquote><p><b>packaging</b></p></blockquote></blockquote></div>"
},
"identifier" : [
{
"system" : "http://ema.europa.eu/example/pcid"
}
],
"packageFor" : [
{
🔗 "reference" : "MedicinalProductDefinition/Xylocain-20mgml-InjSol-SE-AJ-MPD"
}
],
"containedItemQuantity" : [
{
"value" : 5,
"unit" : "Vial",
"system" : "http://spor.ema.europa.eu/v1/lists/200000000014",
"code" : "200000002158"
}
],
"description" : "Injektionsflaska, 5 x 20 ml",
"marketingStatus" : [
{
"country" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000000002",
"code" : "100000000535",
"display" : "Kingdom of Sweden"
}
]
},
"status" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000072052",
"code" : "100000072083",
"display" : "Marketed"
}
]
}
}
],
"packaging" : {
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000073346",
"code" : "100000073498",
"display" : "Box"
}
]
},
"quantity" : 1,
"material" : [
{
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/200000003199",
"code" : "200000003529",
"display" : "Cardboard"
}
]
}
],
"packaging" : [
{
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000073346",
"code" : "100000073563",
"display" : "Vial"
}
]
},
"quantity" : 5,
"material" : [
{
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/200000003199",
"code" : "200000003203",
"display" : "Glass"
}
]
}
],
"containedItem" : [
{
"item" : {
"reference" : {
🔗 "reference" : "ManufacturedItemDefinition/Xylocain-20mgml-InjSol-SE-AJ-MID"
}
},
"amount" : {
"value" : 20,
"unit" : "millilitre(s)",
"system" : "http://spor.ema.europa.eu/v1/lists/100000110633",
"code" : "100000110662"
}
}
]
}
]
}
}
},
{
"fullUrl" : "https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/ManufacturedItemDefinition/Xylocain-20mgml-InjSol-SE-AJ-MID",
"resource" : {
"resourceType" : "ManufacturedItemDefinition",
"id" : "Xylocain-20mgml-InjSol-SE-AJ-MID",
"meta" : {
"profile" : [
🔗 "http://unicom-project.eu/fhir/StructureDefinition/PPLManufacturedItemDefinition"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"ManufacturedItemDefinition_Xylocain-20mgml-InjSol-SE-AJ-MID\"> </a><p class=\"res-header-id\"><b>Generated Narrative: ManufacturedItemDefinition Xylocain-20mgml-InjSol-SE-AJ-MID</b></p><a name=\"Xylocain-20mgml-InjSol-SE-AJ-MID\"> </a><a name=\"hcXylocain-20mgml-InjSol-SE-AJ-MID\"> </a><a name=\"hcXylocain-20mgml-InjSol-SE-AJ-MID-en-US\"> </a><p><b>status</b>: Active</p><p><b>manufacturedDoseForm</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/200000000004 100000073863}\">Solution for injection</span></p><p><b>unitOfPresentation</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/200000000014 200000002158}\">Vial</span></p></div>"
},
"status" : "active",
"manufacturedDoseForm" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/200000000004",
"code" : "100000073863",
"display" : "Solution for injection"
}
]
},
"unitOfPresentation" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/200000000014",
"code" : "200000002158",
"display" : "Vial"
}
]
}
}
},
{
"fullUrl" : "https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/Ingredient/Xylocain-20mgml-InjSol-SE-AJ-ING",
"resource" : {
"resourceType" : "Ingredient",
"id" : "Xylocain-20mgml-InjSol-SE-AJ-ING",
"meta" : {
"profile" : [
🔗 "http://unicom-project.eu/fhir/StructureDefinition/PPLIngredient"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Ingredient_Xylocain-20mgml-InjSol-SE-AJ-ING\"> </a><p class=\"res-header-id\"><b>Generated Narrative: Ingredient Xylocain-20mgml-InjSol-SE-AJ-ING</b></p><a name=\"Xylocain-20mgml-InjSol-SE-AJ-ING\"> </a><a name=\"hcXylocain-20mgml-InjSol-SE-AJ-ING\"> </a><a name=\"hcXylocain-20mgml-InjSol-SE-AJ-ING-en-US\"> </a><p><b>status</b>: Active</p><p><b>for</b>: </p><ul><li><a href=\"MedicinalProductDefinition-Xylocain-20mgml-InjSol-SE-AJ-MPD.html\">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100001718-00003553,http://ema.europa.eu/fhir/eurdId#10934; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Solution for injection; indication = Intravenös regional anestesi, infiltrationsanestesi, nervblockader, epiduralanestesi. Anestesi av fingrar, tår, öron, näsa och penis eller i andra fall då adrenalin anses kontraindicerat. Vid små operativa ingrepp, då mycket kortvarig anestesi önskas. Xylocain 5 mg/ml och Xylocain 10 mg/ml är avsett för vuxna och barn över 1 år. Xylocain 20 mg/ml är avsett för vuxna.; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = lidocaine</a></li><li><a href=\"ManufacturedItemDefinition-Xylocain-20mgml-InjSol-SE-AJ-MID.html\">ManufacturedItemDefinition: status = active; manufacturedDoseForm = Solution for injection; unitOfPresentation = Vial</a></li><li><a href=\"AdministrableProductDefinition-Xylocain-20mgml-InjSol-SE-AJ-APD.html\">AdministrableProductDefinition: status = active; administrableDoseForm = Solution for injection</a></li></ul><p><b>role</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000072050 100000072072}\">Active</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://spor.azure-api.net/sms/api/v2/SubstanceDefinition 100000090563}\">Lidocaine hydrochloride monohydrate</span></td></tr></table><blockquote><p><b>strength</b></p><p><b>concentration</b>: 21.33 milligram(s)<span style=\"background: LightGoldenRodYellow\"> (Details: 100000110633 code100000110655 = '100000110655')</span>/1 millilitre(s)<span style=\"background: LightGoldenRodYellow\"> (Details: 100000110633 code100000110662 = '100000110662')</span></p><blockquote><p><b>referenceStrength</b></p><h3>Substances</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://spor.azure-api.net/sms/api/v2/SubstanceDefinition 100000091713}\">Lidocaine</span></td></tr></table><p><b>strength</b>: 17.31 milligarm(s)<span style=\"background: LightGoldenRodYellow\"> (Details: Unit of Measurement EMA code100000110655 = 'milligram(s)')</span>/1 millilitre(s)<span style=\"background: LightGoldenRodYellow\"> (Details: Unit of Measurement EMA code100000110662 = 'millilitre(s)')</span></p></blockquote><blockquote><p><b>referenceStrength</b></p><h3>Substances</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://spor.azure-api.net/sms/api/v2/SubstanceDefinition 100000139489}\">Lidocaine hydrochloride</span></td></tr></table><p><b>strength</b>: 20 milligram(s)<span style=\"background: LightGoldenRodYellow\"> (Details: Unit of Measurement EMA code100000110655 = 'milligram(s)')</span>/1 millilitre(s)<span style=\"background: LightGoldenRodYellow\"> (Details: Unit of Measurement EMA code100000110662 = 'millilitre(s)')</span></p></blockquote></blockquote></blockquote></div>"
},
"status" : "active",
"for" : [
{
🔗 "reference" : "MedicinalProductDefinition/Xylocain-20mgml-InjSol-SE-AJ-MPD"
},
{
🔗 "reference" : "ManufacturedItemDefinition/Xylocain-20mgml-InjSol-SE-AJ-MID"
},
{
🔗 "reference" : "AdministrableProductDefinition/Xylocain-20mgml-InjSol-SE-AJ-APD"
}
],
"role" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000072050",
"code" : "100000072072",
"display" : "Active"
}
]
},
"substance" : {
"code" : {
"concept" : {
"coding" : [
{
"system" : "https://spor.azure-api.net/sms/api/v2/SubstanceDefinition",
"code" : "100000090563",
"display" : "Lidocaine hydrochloride monohydrate"
}
]
}
},
"strength" : [
{
"concentrationRatio" : {
"numerator" : {
"value" : 21.33,
"unit" : "milligram(s)",
"system" : "http://spor.ema.europa.eu/v1/lists/100000110633",
"code" : "100000110655"
},
"denominator" : {
"value" : 1,
"unit" : "millilitre(s)",
"system" : "http://spor.ema.europa.eu/v1/lists/100000110633",
"code" : "100000110662"
}
},
"referenceStrength" : [
{
"substance" : {
"concept" : {
"coding" : [
{
"system" : "https://spor.azure-api.net/sms/api/v2/SubstanceDefinition",
"code" : "100000091713",
"display" : "Lidocaine"
}
]
}
},
"strengthRatio" : {
"numerator" : {
"value" : 17.31,
"unit" : "milligarm(s)",
"system" : "https://spor.ema.europa.eu/v1/lists/100000110633",
"code" : "100000110655"
},
"denominator" : {
"value" : 1,
"unit" : "millilitre(s)",
"system" : "https://spor.ema.europa.eu/v1/lists/100000110633",
"code" : "100000110662"
}
}
},
{
"substance" : {
"concept" : {
"coding" : [
{
"system" : "https://spor.azure-api.net/sms/api/v2/SubstanceDefinition",
"code" : "100000139489",
"display" : "Lidocaine hydrochloride"
}
]
}
},
"strengthRatio" : {
"numerator" : {
"value" : 20,
"unit" : "milligram(s)",
"system" : "https://spor.ema.europa.eu/v1/lists/100000110633",
"code" : "100000110655"
},
"denominator" : {
"value" : 1,
"unit" : "millilitre(s)",
"system" : "https://spor.ema.europa.eu/v1/lists/100000110633",
"code" : "100000110662"
}
}
}
]
}
]
}
}
},
{
"fullUrl" : "https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/AdministrableProductDefinition/Xylocain-20mgml-InjSol-SE-AJ-APD",
"resource" : {
"resourceType" : "AdministrableProductDefinition",
"id" : "Xylocain-20mgml-InjSol-SE-AJ-APD",
"meta" : {
"profile" : [
🔗 "http://unicom-project.eu/fhir/StructureDefinition/PPLAdministrableProductDefinition"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"AdministrableProductDefinition_Xylocain-20mgml-InjSol-SE-AJ-APD\"> </a><p class=\"res-header-id\"><b>Generated Narrative: AdministrableProductDefinition Xylocain-20mgml-InjSol-SE-AJ-APD</b></p><a name=\"Xylocain-20mgml-InjSol-SE-AJ-APD\"> </a><a name=\"hcXylocain-20mgml-InjSol-SE-AJ-APD\"> </a><a name=\"hcXylocain-20mgml-InjSol-SE-AJ-APD-en-US\"> </a><p><b>status</b>: Active</p><p><b>formOf</b>: <a href=\"MedicinalProductDefinition-Xylocain-20mgml-InjSol-SE-AJ-MPD.html\">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100001718-00003553,http://ema.europa.eu/fhir/eurdId#10934; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Solution for injection; indication = Intravenös regional anestesi, infiltrationsanestesi, nervblockader, epiduralanestesi. Anestesi av fingrar, tår, öron, näsa och penis eller i andra fall då adrenalin anses kontraindicerat. Vid små operativa ingrepp, då mycket kortvarig anestesi önskas. Xylocain 5 mg/ml och Xylocain 10 mg/ml är avsett för vuxna och barn över 1 år. Xylocain 20 mg/ml är avsett för vuxna.; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = lidocaine</a></p><p><b>administrableDoseForm</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/200000000004 100000073863}\">Solution for injection</span></p><p><b>producedFrom</b>: <a href=\"ManufacturedItemDefinition-Xylocain-20mgml-InjSol-SE-AJ-MID.html\">ManufacturedItemDefinition: status = active; manufacturedDoseForm = Solution for injection; unitOfPresentation = Vial</a></p><blockquote><p><b>routeOfAdministration</b></p><p><b>code</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000073345 100000073611}\">Intravenous use</span></p></blockquote><blockquote><p><b>routeOfAdministration</b></p><p><b>code</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000073345 100000073572}\">Epidural use</span></p></blockquote><blockquote><p><b>routeOfAdministration</b></p><p><b>code</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000073345 100000073624}\">Perineural use</span></p></blockquote></div>"
},
"status" : "active",
"formOf" : [
{
🔗 "reference" : "MedicinalProductDefinition/Xylocain-20mgml-InjSol-SE-AJ-MPD"
}
],
"administrableDoseForm" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/200000000004",
"code" : "100000073863",
"display" : "Solution for injection"
}
]
},
"producedFrom" : [
{
🔗 "reference" : "ManufacturedItemDefinition/Xylocain-20mgml-InjSol-SE-AJ-MID"
}
],
"routeOfAdministration" : [
{
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000073345",
"code" : "100000073611",
"display" : "Intravenous use"
}
]
}
},
{
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000073345",
"code" : "100000073572",
"display" : "Epidural use"
}
]
}
},
{
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000073345",
"code" : "100000073624",
"display" : "Perineural use"
}
]
}
}
]
}
},
{
"fullUrl" : "https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/Organization/LOC-100001575",
"resource" : {
"resourceType" : "Organization",
"id" : "LOC-100001575",
"meta" : {
"profile" : [
🔗 "http://unicom-project.eu/fhir/StructureDefinition/PPLOrganization"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Organization_LOC-100001575\"> </a><p class=\"res-header-id\"><b>Generated Narrative: Organization LOC-100001575</b></p><a name=\"LOC-100001575\"> </a><a name=\"hcLOC-100001575\"> </a><a name=\"hcLOC-100001575-en-US\"> </a><p><b>identifier</b>: <code>https://spor.ema.europa.eu/v1/locations</code>/LOC-100001575</p><p><b>name</b>: Aspen Pharma Trading Limited</p></div>"
},
"identifier" : [
{
"system" : "https://spor.ema.europa.eu/v1/locations",
"value" : "LOC-100001575"
}
],
"name" : "Aspen Pharma Trading Limited"
}
}
]
}
IG © 2022+ UNICOM. Package hl7.eu.fhir.ufis-swe-unicom#0.1.0 based on FHIR 5.0.0. Generated 2024-06-28
Links: Table of Contents |
QA Report
The UNICOM Innovation Action has received funding from the European Union's Horizon 2020
research and innovation programme under grant agreement No. 875299.
